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Apoptosis of mature T lymphocytes preserves immune system homeostasis by counteracting transient
increases in T-cell number. This process is regulated, at least in part, by the cytokine interleukin 2 (IL-2): T
cells deprived of IL-2 undergo apoptosis. The mechanism of apoptosis induction by IL-2 deprivation remains
to be determined but is known to require RNA synthesis, implying the existence of transcriptionally activated
genes whose products induce cell death. To identify such genes, we have performed expression profiling in
IL-2-dependent T cells following cytokine deprivation. Our results reveal an intricate transcriptional program
entailing the induction of known proapoptotic factors and the simultaneous repression of known antiapoptotic
factors. Surprisingly, one gene whose transcription substantially increased was RC3 (also called neurogranin),
which encodes a calmodulin binding protein thought to be a neural-specific factor involved in learning and
memory. We show that ectopic expression of RC3 in IL-2-dependent T cells increases the intracellular Ca2
concentration and induces apoptosis even in the presence of cytokine. Buffering the Ca2 increase with the
cytoplasmic Ca2 chelator BAPTA-AM [1,2-bis(2-aminophenoxy)ethane-N,N,N1,N-tetraacetic acid] blocks
RC3-induced apoptosis, indicating that the rise in intracellular Ca2 is required for apoptotic death. RC3
mutants unable to bind calmodulin fail to increase intracellular Ca2 levels and to induce apoptosis. Based
upon these results, we propose that IL-2 deprivation raises the level of RC3 and other apoptotic factors, which
induce apoptosis by increasing the intracellular Ca2 concentration.
A complex network of cytokines controls the development,
maturation, homeostasis, and responses of the immune system.
An immune response typically involves a large increase in ac-
tivated T cells, which must be eliminated following termination
of the response to preserve homeostasis. This is achieved by apo-
ptosis (also called programmed cell death), which can result
from either cytokine deprivation or T-cell receptor activation
(19). The cytokine interleukin 2 (IL-2) is produced and secret-
ed by activated T cells and controls lymphocyte survival and cell
cycle progression (17), and paradoxically it can also facilitate a
particular apoptotic program in T lymphocytes termed activa-
tion-induced cell death (25). When deprived of IL-2, cycling T
cells cease to proliferate and rapidly undergo apoptosis (19).
A key component of the apoptotic machinery is a proteolytic
system involving an evolutionarily conserved family of cysteine
aspartate proteases called caspases. Although this machinery is
common to many forms of apoptosis, the precise mechanisms
by which it becomes activated can vary considerably. Two path-
ways leading to caspase activation have been characterized: the
extrinsic pathway, which involves so-called death receptors,
and the intrinsic pathway, which involves the release of pro-
apoptotic proteins from the mitochondria. In addition, some
apoptotic pathways are transcription dependent, whereas oth-
ers entail a purely posttranscriptional signal transduction cas-
cade.
There have been several proposals for the mechanism by
which IL-2 deprivation leads to apoptosis, including regulation
of Bcl-2 family members, modulation of second messengers,
and alteration of the activity of protein kinases or phospha-
tases (1, 5, 11). However, none of these regulatory events
explain the requirement of de novo RNA or protein synthesis
for induction of apoptosis following IL-2 deprivation (10).
Here we use expression profiling to identify death-promoting
genes that are transcriptionally activated in lymphocytes fol-
lowing IL-2 deprivation.
MATERIALS AND METHODS
Plasmids and cell culture. RC3 cDNA was hemagglutinin tagged at the 3 end
and cloned into pcDNA3.1 and pcDNA3.1 vectors (Invitrogen). IL-2-depen-
dent murine HT-2 (T helper) cells, CTLL-2 (cytotoxic T) cells, myeloid 32D
cells, HEK-293 cells, and human T-cell leukemia Jurkat cells were all obtained
from the American Type Culture Collection; IL-3-dependent murine FL5.12
cells (pro-B lymphocytes) were provided by Craig Thompson (University of
Pennsylvania). HT-2 and CTLL-2 cells were maintained in RPMI 1640 medium
(GIBCO-BRL) supplemented with 10% fetal bovine serum (FBS), 2 mM L-
glutamine (GIBCO-BRL), 1 mM sodium pyruvate (GIBCO-BRL), 100 U of
penicillin (Sigma) per ml, 100 g of streptomycin (Sigma) per ml, 0.05 mM
2-mercaptoethanol (GIBCO-BRL), and 200 U of recombinant IL-2 (PharMin-
gen) per ml or 10% rat T-STIM factor with concanavalin A (Becton Dickinson).
FL5.12 and 32D cells were maintained in RPMI medium supplemented with
10% FBS, 1 mM L-glutamine, 100 U of penicillin per ml, 100 g of streptomycin
per ml, 0.05 mM 2-mercaptoethanol, and 3 ng of recombinant IL-3 (PharMin-
gen) per ml. HEK-293 cells were maintained in Dulbecco’s modified Eagle’s
medium supplemented with 10% FBS, 1 mM L-glutamine, 100 U of penicillin per
ml, and 100 mg of streptomycin per ml. Jurkat cells were maintained in RPMI
medium supplemented with 10% FBS, 1 mM L-glutamine, 100 U of penicillin per
ml, and 100 mg of streptomycin per ml.
Human peripheral blood lymphocytes from healthy donors were initially cul-
tured in RPMI medium supplemented with 10% FBS, 1 mM L-glutamine, and 5
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g of phytohemagglutinin (Sigma) per ml for 2 days. Cells were then collected
and placed in RPMI containing 10% FBS and 10% human IL-2 (Advanced
Biotechnologies) for 4 days with a medium change every 48 h. Staurosporine
(Sigma) and thapsigargin (Calbiochem) were added to the media to final con-
centrations of 10 and 2 M, respectively. BAPTA-AM [1,2-bis(2-aminophe-
noxy)ethane-N,N,N1,N-tetraacetic acid] (Sigma) was added to the media to a
final concentration of 25 M.
Microarray analysis. HT-2 cells were cultured in the presence of IL-2 and
subjected to IL-2 deprivation as described previously (10). Poly(A) mRNA was
isolated at 8 h following IL-2 withdrawal by using an Oligotex direct mRNA
isolation kit (Qiagen). The integrity of mRNA was monitored by a Northern blot
assay with a glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH) probe.
Two micrograms of mRNA was used to generate a cDNA library by using an
oligo(dT) T7 primer and Superscript cDNA synthesis system (GIBCO-BRL)
according to the manufacturer’s instructions. The cDNA library was in vitro
transcribed with biotinylated nucleotides by using the T7 Megascript kit (Am-
bion) according to the manufacturer’s instructions. The resulting cRNA was
fragmented by heating at 94°C for 30 min. GeneChip Murine 19K and 11K
Affymetrix oligonucleotide arrays representing 30,000 known genes or ex-
pressed sequence tags were hybridized with fragmented cRNA overnight at 37°C.
Following washing, the chips were scanned and analyzed with Affymetrix mi-
croarray suite software. The complete data set is available upon request.
Transient transfections and apoptotic assays. HT-2, CTLL-2, and FL5.12 cells
were transfected with plasmids by using Superfect transfection reagent (Qiagen)
according to the manufacturer’s instructions. Cells were collected 24 h after
transfection and stained with annexin V-fluorescein isothiocyanate (FITC)-pro-
pidium iodide (Oncogene). For cotransfection experiments, HT-2 cells were
cotransfected with 1 g of enhanced green fluorescent protein (GFP) plasmid
(Clontech) and 4 g of pcDNA3.1/RC3 (sense orientation) or pcDNA3.1/
RC3 (antisense orientation). Cotransfected cells were stained with annexin V-
phycoerythrin (PE) (PharMingen) and analyzed by fluorescence-activated cell
sorting (FACS) analysis. At least two independent experiments were performed,
and the results are presented as the averages  standard deviations.
For HEK-293 fibroblasts, cells were seeded into a Lab-Tek II chamber slide
(Nunc) at 6  105 cells per slide and cotransfected with 0.5 g of -galactosidase
reporter plasmid (Clontech) and 4 g of expression plasmid (as indicated), using
Superfect transfection reagent. Following transfection, cells were washed three
times with phosphate-buffered saline, fixed with 0.5% glutaraldehyde, and
stained with 0.2% 5-bromo-4-chloro-3-indolyl--D-galactoside (X-Gal) (Pro-
mega) as described previously (20). The percentage of transfected (blue) cells
with apoptotic morphology was determined. At least two independent experi-
ments were performed, and the results are presented as the averages  standard
deviations.
For DNA fragmentation analysis, DNA from 2  106 cells was isolated by
phenol extraction 24 h following transfection and analyzed on a 1% agarose gel
as previously described (32).
Fluorospectrometric analysis of intracellular calcium concentration. To mea-
sure intracellular Ca2 concentrations, 5  106 HT-2 cells were stained with 2
mM fura-2 AM (Molecular Probes), a fluorescent Ca2 indicator, in 1 ml of
saline containing 1 mM CaCl2. Cells were stained for 30 min at 37°C and for 10
min at room temperature. The cells were washed two times with saline contain-
ing 1 mM CaCl2 and resuspended at 106 cells/ml in the same solution. Spectro-
metric analysis was performed at 380 and 340 nm as described previously (36).
The Ca2 ionophore ionomycin was added to a final concentration of 10 mM at
the end of each experiment to determine whether the limits of saturation of
fura-2 AM had been reached. At least two independent experiments were per-
formed, and the results are presented as the averages  standard deviations.
Single-cell Ca2 imaging. Intracellular Ca2 was measured in primary human
T lymphocytes and in HT-2 cells transfected with the RC3 expression plas-
mid. HT-2 cells were cotransfected with 5 g of either pcDNA3.1/RC3 or
pcDNA3.1 and a plasmid expressing the truncated human CD4 molecule as a
marker to select transfected cells. Transfected cells were then isolated from
untransfected cells by using the MACSelect-transfected cell isolation kit (Mil-
tenyi Biotech) according to the manufacturer’s instructions. Transfected cells
were then stained with 3 M fura-2 AM in RPMI for 20 min at room temper-
ature. Cells were washed three times with RPMI and plated onto poly-D-lysine-
coated glass-bottom dishes (Mattek Corporation) for 10 min at room tempera-
ture. Cells were washed once with Ringer lactate solution. Images were collected
at 340- and 380-nm wavelengths. Single-cell measurements of intracellular Ca2
ion concentration were calculated from the 340 nm/380 nm ratios (generated
from background-corrected 340 nm/380 nm images) by using the equation of
Grynkiewicz et al. (18) and a Kd of 250 nM for fura-2 AM. At least two
independent experiments were performed, and the results are presented as the
averages  standard deviations.
RESULTS
Identification of genes transcriptionally activated in T cells
following IL-2 deprivation. The mouse HT-2 T helper cell line
requires IL-2 for growth, and in its absence HT-2 cells undergo
apoptosis (Fig. 1A) (34). For expression profiling, HT-2
poly(A) mRNA was isolated 8 h after IL-2 withdrawal and
used to interrogate Affymetrix DNA chips that contained
30,000 genes or expressed sequence tags. Comparison of the
transcription profiles of cells grown in the presence or absence
of IL-2 revealed that 97% of the genes were unaffected by
cytokine deprivation (Fig. 1B). Of the genes whose transcrip-
tion was altered by cytokine deprivation, surprisingly, approx-
imately three-quarters were stimulated and one-quarter were
repressed (Fig. 1C).
Several of the genes that underwent significant transcrip-
tional changes following IL-2 deprivation are listed in Table 1.
Three of the genes that underwent transcriptional stimulation
were CAPN5, encoding a calpain cysteine protease; DRP-1,
which encodes death-associated protein kinase (DAPK)-re-
lated protein 1 (21); and RC3/neurogranin, encoding a calmod-
ulin (CaM) binding protein (4). The apoptotic roles of calpains
and DRP-1 are well documented (21, 24). DRP-1 encodes a
CaM-regulated serine/threonine kinase that is highly similar to
DAPK. Both kinases contain a CaM binding domain, and,
interestingly, ectopic expression of either DRP-1 or DAPK
induces apoptosis in a wide variety of cell types (6, 21).
Conversely, transcription of a number of genes decreased
following IL-2 deprivation, including the Pim1 oncogene (33)
and ATFx, which encodes a basic-region leucine zipper (bZIP)
transcription factor (28) (Table 1). Significantly, expression of
Pim1 and ATFx is also repressed following cytokine depriva-
tion in IL-3-dependent FL5.12 cells (8), and both genes encode
proteins with antiapoptotic activities (30, 35).
The finding that RC3 was transcriptionally activated in lym-
phocytes was surprising, because the RC3 protein was previ-
ously characterized as a neurally specific factor involved in
synaptic plasticity and spatial learning (29, 37). Therefore, RC3
represented a putative novel gene involved in lymphocyte apo-
ptosis, and we sought to test this hypothesis and study the
mechanism of RC3 action. Northern blot analysis confirmed
the results of the DNA microarray experiments: IL-2 with-
drawal resulted in transcriptional activation of RC3 and repres-
sion of ATFx (Fig. 2A). A time course analysis revealed that
RC3 transcriptional induction preceded the onset of apoptosis
(Fig. 2B). Immunoblot analysis showed that like the mRNA
levels, RC3 protein levels were also up-regulated following
IL-2 withdrawal (Fig. 2C).
Specificity of RC3 transcriptional activation. To investigate
the specificity of RC3 transcriptional activation, we analyzed
several other cytokine-dependent cell lines: IL-2-dependent
CTLL-2 cells, IL-2-dependent primary human T lymphocytes,
IL-3-dependent murine pro-B lymphocytic FL5.12 cells, and
IL-3-dependent murine myeloid 32D cells. Similar to the re-
sults obtained with the IL-2-dependent HT-2 cell line, tran-
scription of RC3 was also activated in CTLL-2 cells (Fig. 3A)
and in IL-2-dependent primary human T lymphocytes (Fig.
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3B) following cytokine deprivation. However, the results with
the IL-3-dependent cell lines differed. Although RC3 mRNA
could be detected in FL5.12 cells grown in the presence of
IL-3, the mRNA levels were not significantly increased follow-
ing cytokine deprivation (Fig. 3C). In IL-3-dependent 32D
cells, RC3 mRNA was not detected in either the presence or
absence of cytokine (Fig. 3D). Transcriptional activation of
RC3 also did not occur in cytokine-deprived IL-7-dependent
D1-F4 cells or serum-deprived human fibroblasts (data not
shown). Finally, we analyzed RC3 expression in a cytokine-
independent T-cell line (human T-cell leukemia Jurkat cells).
Apoptosis was induced in Jurkat cells with staurosporine, and
FIG. 1. A transcriptional program of apoptosis induction following
IL-2 deprivation. (A) Time course of apoptosis following IL-2 depri-
vation. The percentage of viable HT-2 cells was determined by annexin
V-FITC staining. (B) Summary of microarray analysis. Affected is de-
fined as a twofold or greater change following IL-2 deprivation. (C)
Graphical representation of the fold changes of genes stimulated or
repressed.
FIG. 2. Induction of RC3 transcription following IL-2 deprivation.
(A) Transcriptional activation of RC3 upon IL-2 deprivation. Expres-
sion of RC3, ATFx, and GAPDH (as a loading control) in HT-2 cells
was assessed by Northern blot analysis with 1 g of poly(A) mRNA
or 10 g of total RNA 8 h after IL-2 deprivation. (B) Time course of
RC3 induction. RC3 mRNA levels in HT-2 cells were analyzed at the
indicated times following IL-2 deprivation. The Northern blot was
stripped and reprobed with a 28S rRNA probe as a loading control.
(C) Immunoblot analysis of whole-cell extracts (Lysate) or culture
supernatants (Supt) from HT-2 cells grown in the presence or absence
of IL-2. The same blot was stripped and reprobed with an 	-tubulin
antibody (Sigma) as a loading control. The exposure time was 10 s.
TABLE 1. Selected genes whose transcription was altered
following IL-2 deprivation of HT-2 cellsa
Gene Fold change intranscription
CAPN5 .........................................................................................26.7
DRP-1 ..........................................................................................25.0
RC3 ..............................................................................................15.6
ATFx ............................................................................................ 5.5
Pim1/2 kinase gene ....................................................................78.0
a Known proapoptotic genes that underwent more than a 15-fold induction
and known antiapoptotic genes that underwent more than a 5-fold repression are
shown. RC3 is the subject of this study.
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RC3 protein levels were analyzed by immunoblot analysis.
Although staurosporine treatment resulted in proteolytic acti-
vation of the apoptotic marker caspase 3, expression of RC3
was not detected (Fig. 3E). Collectively, these results indicate
that RC3 transcriptional activation is not a general conse-
quence of apoptosis induction due to growth factor depriva-
tion.
Ectopic RC3 expression induces apoptosis. To investigate
whether overexpression of RC3 was sufficient to induce apo-
ptosis, we transfected IL-2-dependent HT-2 and CTLL-2 cells
and IL-3-dependent FL5.12 cells with a plasmid expressing
RC3. After 24 h, cells were stained with annexin V-FITC-
propidium iodide to monitor apoptosis. Figure 4A shows that
expression of RC3 induced apoptosis in HT-2 and CTLL-2
cells but not in FL5.12 cells. As expected, transfection of cells
with the expression vector pcDNA3.1 had no effect on either
cell line. Immunoblot analysis revealed that the differential
response of HT-2 and FL5.12 cells was not due to variations in
RC3 expression (Fig. 4B).
The ability of RC3 to induce apoptosis in HT-2 cells was also
investigated by using two other independent assays. In one as-
say, the RC3 expression plasmid was cotransfected with a plas-
mid expressing GFP, which provided a marker for transfected
cells. Quantitation of cells that were both GFP positive and
annexin V-PE positive by FACS analysis confirmed that ec-
topic RC3 expression induced apoptosis (Fig. 4C). As expect-
ed, cotransfection with a plasmid lacking the RC3 coding se-
quence (pcDNA3.1 vector alone) or with RC3 cloned in the
antisense orientation failed to induce apoptosis (Fig. 4C). In
the second assay, DNA extracted from HT-2 and CTLL-2 cells
transfected with an RC3 expression plasmid was analyzed by
using a DNA fragmentation assay. Figure 4D shows that in
both cell types RC3 expression resulted in a characteristic
DNA ladder, confirming that cell death was apoptotic.
A functional RC3 CaM binding domain is required for in-
duction of apoptosis. Alterations in intracellular ion levels are
a feature of several apoptotic pathways, and the involvement of
Ca2 has been well documented. For example, Ca2 iono-
phores, which directly mobilize Ca2 from internal stores, in-
duce apoptosis in diverse cell types (27). Conversely, agents
that decrease intracellular Ca2 concentration can inhibit apo-
ptosis; for example, one of the many activities of the antiapo-
ptotic Bcl-2 protein is to prevent the loss of Ca2 from intra-
cellular stores, thereby blocking apoptosis (2).
Many of the physiological effects of Ca2 are mediated by
CaM, a small, ubiquitous protein that regulates a wide variety
of cellular processes by activating Ca2/CaM-dependent en-
zymes that, in turn, modulate signaling cascades. Like intra-
cellular Ca2, CaM may also regulate apoptosis; for example,
increased CaM expression has been correlated with apoptosis
(9), and, conversely, CaM antagonists can interfere with apo-
ptosis (26).
RC3 contains a well-characterized 20-amino-acid sequence
known as the IQ motif (3), which functions as a binding site for
CaM (12). Specific single amino acid substitutions in the IQ
domain eliminate binding of RC3 to CaM in vivo (31). In the
brain, CaM appears to be the major protein that interacts with
RC3, and the RC3-CaM interaction is believed to be essential
for RC3 function (12, 31). To investigate whether the ability of
RC3 to induce apoptosis correlated with its ability to bind
CaM, we analyzed the apoptotic activity of RC3 derivatives
bearing mutations in the CaM binding domain by using two
different assays. In the first assay, HT-2 cells cultured in the
presence of IL-2 were transfected with plasmids expressing
either wild-type RC3 or an RC3 mutant, and the percentage of
apoptotic cells was determined by annexin V-FITC staining.
Figure 5A shows that mutation of Ile-33 to Gln (I33Q), which
completely inhibits RC3 binding to CaM (31), also eliminated
its proapoptotic activity. Similarly, mutation of either Ser-36 to
Asp (S36D) or Arg-38 to Gln (R38Q), which weakens the
RC3-CaM interaction (31), also reduced the proapoptotic ac-
tivity of RC3. In contrast, the Ser-36-to-Ala mutation (S36A),
FIG. 3. Cell specificity of RC3 transcription activation. (A) RC3 is
transcriptionally activated in CTLL-2 cells upon IL-2 deprivation. Ex-
pression of RC3 and GAPDH (as a loading control) was assessed by
Northern blot analysis with 1 g of poly(A) mRNA or 10 g of total
RNA 8 h after IL-2 removal. (B) Northern blot analysis of poly(A)
mRNA prepared from primary human T lymphocytes 12 to 14 h after
IL-2 removal. (C) Northern blot analysis of poly(A) mRNA prepared
from FL5.12 cells 8 h after IL-3 removal. The same blot was sequen-
tially stripped and reprobed with 24p3 (as an induction control), ATFx
(as a repression control), and GAPDH probes. (D) Northern analysis
of poly(A) mRNA from 32D cells. The blot was probed sequentially
with RC3 and GAPDH probes. (E) Immunoblot analysis of whole-cell
extracts from Jurkat cells after staurosporine (STS) treatment, which
induces apoptosis. The same blot was stripped and reprobed with a
caspase-3 antibody (Santa Cruz Biotechnology) as a control; STS treat-
ment results in proteolytic activation of caspase 3.
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FIG. 4. Expression of RC3 induces apoptosis in HT-2 and CTLL-2 cells. (A) HT-2 and CTLL-2 cells were transiently transfected with 5 g of
either pcDNA3.1 (empty vector) or pcDNA3.1/RC3 or left untransfected (control). One day after transfection, cells were collected and stained with
annexin V-FITC and analyzed by FACS. PI, propidium iodide. (B) Extracts were prepared from a portion of the transfected cells and analyzed
by immunoblotting with an antihemagglutinin (anti-HA) monoclonal antibody or an 	-tubulin antibody. (C) HT-2 cells were cotransfected with
1 g of GFP plasmid and 4 g of either pcDNA3.1 (empty vector), pcDNA3.1/RC3 (sense orientation), or pcDNA3.1-/RC3 (antisense
orientation). Cotransfected cells were stained with annexin V-PE and analyzed by FACS. The percentage of GFP-positive cells that were also
positive for annexin V-PE was quantitated and plotted. Error bars indicate standard deviations. (D) HT-2 and CTLL-2 cells transfected with empty
vector plasmid (pcDNA3.1) or an RC3 expression plasmid were subjected to DNA fragmentation analysis.
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which does not affect the RC3-CaM interaction (31), induced
apoptosis at levels similar to those for wild-type RC3.
In the experiment shown in Fig. 5A, apoptosis was analyzed
in a population in which there was a high background of un-
transfected cells (60%). To confirm these results, we per-
formed a second assay that measured apoptosis only in trans-
fected cells. For these experiments, which involve staining
individual cells, we used the adherent cell line HEK-293. HEK-
293 cells were cotransfected with a -galactosidase reporter
plasmid and a plasmid encoding either the wild-type or mutant
FIG. 5. A functional RC3 CaM binding domain is required for induction of apoptosis. (A) HT-2 cells grown in the presence of IL-2 were
transfected with 4 g of empty vector plasmid (pcDNA3.1), wild-type RC3 (WT), or RC3 mutants. Cells were collected 24 h after transfection,
stained with annexin V-FITC, and subjected to FACS analysis to monitor cell viability. The protein sequence of the 20-amino-acid CaM binding
domain (IQ motif) of RC3 is shown; mutated residues are indicated by arrows. Error bars indicate standard deviations. (B) HEK-293 cells were
transiently cotransfected with a -galactosidase (-gal) reporter plasmid (0.5 g) and the experimental plasmid (4 g), as indicated. The cells were
washed 24 h after transfection, fixed, and stained with 0.2% X-Gal. (C) Quantitative analysis of the experiment for panel B. Four hundred
-galactosidase-positive cells were analyzed, and the number of blue cells displaying an apoptotic morphology was assessed.
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RC3 protein. The cells were then stained with the chromogenic
substrate X-Gal, which marks transfected cells, and apoptotic
cells were identified by their characteristic condensed mor-
phology (Fig. 5B) and quantitatively assessed (Fig. 5C). The
results of this second apoptotic assay were similar to those of
Fig. 5A. Collectively, these results reveal a strong correlation
between the abilities of RC3 to bind CaM and to induce apo-
ptosis.
Both IL-2 deprivation and RC3 expression increase intra-
cellular calcium concentration. An increased intracellular
Ca2 concentration is known to induce apoptosis. We there-
fore reasoned that increased RC3 levels that occur during IL-2
deprivation might trigger apoptosis by sequestering CaM,
thereby releasing Ca2 and increasing the intracellular Ca2
concentration. As an initial test of this hypothesis, we mea-
sured intracellular Ca2 levels in HT-2 cells following IL-2
deprivation. As a positive control, HT-2 cells were treated with
thapsigargin, which releases Ca2 from intracellular pools and
induces apoptosis. Figure 6A shows that thapsigargin treat-
ment increased the intracellular Ca2 concentration 10-fold,
whereas IL-2 deprivation increased the intracellular Ca2 con-
centration 5-fold. We conclude that IL-2 deprivation increases
intracellular Ca2 concentration.
We next asked whether RC3 expression would, like IL-2
deprivation, increase the intracellular Ca2 concentration.
HT-2 cells were transfected with a plasmid expressing RC3 or
an RC3 mutant. Figure 6B shows that the intracellular Ca2
concentration in cells transfected with an RC3 expression plas-
mid was 2.5-fold higher than that in untransfected cells or cells
transfected with the pcDNA3.1 expression plasmid. After cor-
recting for transfection efficiency (40%), we concluded that
RC3 expression increased the intracellular Ca2 concentration
approximately sixfold, which was very similar to the result
observed following IL-2 deprivation. Analysis of two RC3 mu-
tants (R38Q and S36A) again revealed a correlation between
the abilities of RC3 to interact with CaM and to increase
intracellular Ca2. We conclude that RC3 increases the intra-
cellular Ca2 concentration.
To directly quantify the Ca2 increase induced by RC3 ex-
pression, we performed single-cell imaging experiments. HT-2
cells transfected with either an RC3 expression plasmid or
pcDNA3.1 were isolated and subjected to single-cell intracel-
lular Ca2 imaging analysis. The pseudocolor image in Fig. 6C
shows that RC3 expression resulted in an increased intra-
cellular Ca2 concentration. Quantitation revealed that RC3
expression increased the intracellular Ca2 concentration ap-
proximately eightfold, comparable to the approximately nine-
fold increase observed upon IL-2 withdrawal in the same assay,
confirming the results of Fig. 6A and B. Finally, a similar
analysis for IL-2-dependent primary human T lymphocytes
again indicated that RC3 expression increased the intracellular
Ca2 concentration (Fig. 6D).
An increase in intracellular calcium is required for induc-
tion of apoptosis. To determine if the Ca2 increase that oc-
curs following IL-3 withdrawal or RC3 expression is directly
responsible for triggering apoptosis, we asked whether deple-
tion of intracellular Ca2 could protect cells from apoptotic
death. Incubation in the presence of BAPTA-AM, an intracel-
lular Ca2 chelator, inhibited apoptosis induced by cytokine
deprivation in IL-2-dependent HT-2 cells (Fig. 7A) and in
IL-2-dependent primary human T lymphocytes (Fig. 7B). Sim-
ilarly, BAPTA-AM treatment abolished the apoptotic effects
of RC3 expression (Fig. 7C). These results indicate that intra-
cellular free Ca2 accumulation plays a critical role in apopto-
sis induced by either IL-2 deprivation or RC3 expression.
DISCUSSION
We have found that induction of apoptosis due to cytokine
deprivation in IL-2-dependent lymphocytes involves an orches-
trated transcriptional program in which genes encoding pro-
apoptotic factors are transcriptionally activated and genes en-
coding antiapoptotic factors are transcriptionally repressed. In
addition, we have identified a novel proapoptotic factor, RC3,
a member of the calpacitin family, whose members bind and
release CaM in response to Ca2 flux (13). The role of RC3 in
modulating intracellular Ca2 and CaM levels in neurons is
well documented (13). Our studies reveal that RC3 also has a
function in lymphocytes. We find that RC3 is transcriptionally
activated in IL-2-dependent T cells following cytokine depri-
vation and that ectopic expression of RC3 in these cells induces
apoptosis. These results suggest a model in which RC3 plays a
role in eliminating activated T cells following an immune re-
sponse. Consistent with a potential role in the immune re-
sponse, previous studies have shown that in addition to the
brain, RC3 is expressed in the spleen and thymus (16, 37). RC3
knockout mice have been derived (29), and it will be important
to carefully evaluate their immunological status.
Although the mechanism by which IL-2 promotes transcrip-
tion has been well characterized (reviewed in reference 15),
the pathway by which IL-2 deprivation increases transcription
of RC3 and other genes remains to be elucidated. One poten-
tial clue has come from studies with IL-2-dependent mouse
lymphoid cells, which show that expression of the AP-1 tran-
scription factors c-Fos and c-Jun is rapidly induced following
growth factor deprivation (7). The RC3 promoter contains
putative AP-1 binding sites (22), suggesting a possible mecha-
nism for transcriptional activation of RC3 following IL-2 de-
privation.
The proapoptotic activity of RC3 requires a functional CaM
binding domain, indicating that the ability of RC3 to induce
apoptosis is related to its role in modulating intracellular CaM
and/or Ca2 levels. Recent computer-based modeling of cal-
pacitin-CaM interactions predicts that increased RC3 levels
would lead to dissociation of the Ca2-CaM complex, thereby
increasing intracellular Ca2 levels (14). Consistent with this
prediction, we found that overexpression of RC3 resulted in an
increased intracellular Ca2 concentration (Fig. 6).
Based on the findings presented in this report and previous
studies on calpacitin regulation and function, we propose the
following model for the induction of apoptosis by RC3 in
lymphoid cells. IL-2 deprivation induces RC3 expression, and
the elevated levels of RC3 sequester CaM and stabilize it in its
Ca2-free form, which, as described above, contributes to an
increase in intracellular Ca2 and triggers apoptosis. In sup-
port of this model, antisense-mediated blocking of the Ca2
channel renders T cells resistant to apoptosis, indicating that
intracellular Ca2 levels play a role in T-cell apoptosis (23).
IL-2 deprivation may also decrease protein kinase C (PKC)
activity (17). PKC phosphorylates RC3 and blocks the RC3-
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FIG. 6. Both IL-2 deprivation and RC3 expression increase intracellular Ca2 concentration. (A) HT-2 cells grown in the presence or absence
of IL-2 for 12 h were stained with the fluorescent Ca2 indicator fura-2 AM, and the intracellular Ca2 concentration was measured (see Materials
and Methods for details). As a control, HT-2 cells were treated with 2 M thapsigargin (TSG), a Ca2 store depletor, for 1 min before staining
with fura-2 AM. Error bars indicate standard deviations. (B) HT-2 cells were transfected with a plasmid expressing RC3 or an RC3 mutant and
analyzed as described for panel A. WT, wild type. (C) HT-2 cells were transfected with either pcDNA3.1 or an RC3 expression plasmid; transfected
cells were isolated from untransfected cells (see Materials and Methods for details) and, in parallel with controls with or without IL-2, stained with
fura-2 AM. The left panels show the pseudocolor images of intracellular Ca2 within fura-2-loaded cells; high Ca2 levels are shown in red, and
low Ca2 levels are shown in blue or violet. Cells cultured in the absence of IL-2 or expressing RC3 display an apoptotic morphology. The average
intracellular Ca2 concentration of the cells shown in each field of view was calculated from background corrected images (see Materials and
Methods) and is shown in the panel on the right. (D) Primary human T lymphocytes were grown in the presence or absence of IL-2 for 12 to 14 h
and stained with fura-2 AM. The left panels show the pseudocolor images, and the right panel shows the average intracellular Ca2 concentration
as described for panel C.
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CaM interaction (12). Thus, a reduction in PKC phosphoryla-
tion should stabilize the Ca2-free form of CaM, which would
also increase the intracellular Ca2 concentration. Finally,
RC3 could also increase intracellular Ca2 and induce apo-
ptosis by regulating the association of Ca2/CaM with various
proteins, thereby modulating other CaM-dependent pathways.
One such protein may be the CaM-dependent plasma mem-
brane Ca2-ATPase; a decreased efflux of intracellular Ca2
could contribute to the Ca2 increase.
The ability of a CaM binding protein to induce apoptosis
when overexpressed has also been demonstrated with two pro-
apoptotic serine/threonine kinases: DAPK and DRP-1. In-
triguingly, like that of RC3, expression of DRP-1 is also in-
creased following IL-2 deprivation (Table 1). DRP-1 has been
shown to induce apoptosis when expressed in a variety of cell
lines (21), and both RC3 and DRP-1 have similar IQ motif
CaM binding domains. It therefore appears that IL-2 depriva-
tion increases the level of multiple CaM-interacting proteins
that activate parallel apoptotic pathways, thus ensuring effi-
cient onset of apoptosis.
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